コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 a recently described 18- kDa heparin binding growth/differentiation factor.
2 en cultured in presence of Gdf11, a TGF-beta growth/differentiation factor.
3 n (PAH) by selectively trapping activins and growth differentiation factors.
4 ction of various heparin-binding polypeptide growth/differentiation factors.
5 nown factor is cVg1 (homologous to mammalian growth differentiation factor 1, GDF1), a transforming g
7 gnificant induction of circulating levels of growth differentiation factor 10 (GDF10) in TDAG51(-/-)
8 lin-dependent kinase-4 (cdk4) and -6 (cdk6), growth differentiation factor 10 (Gdf10), hepatocyte gro
9 y elevated expression of the TGF-beta ligand growth differentiation factor-10 (GDF10), which was foun
14 pothesis that the circulating blood level of growth differentiation factor 11 (GDF11) decreases in ol
16 we demonstrate that the circulating protein growth differentiation factor 11 (GDF11) is a rejuvenati
18 Prior studies suggested that inhibition of growth differentiation factor 11 (GDF11) through soluble
20 ing OE at the same time as the gene encoding growth differentiation factor 11 (Gdf11), a TGFbeta fami
24 g growth factors, such as BMP2/4, myostatin, growth differentiation factor 11, and transforming growt
26 eport a tumor-suppressive mode of action for growth-differentiation factor 11 (GDF11) and an unusual
27 egulates the expression of the gene encoding growth-differentiation factor 11 (Gdf11), a transforming
28 al cell line-derived neurotrophic factor and growth-differentiation factor 11 was defective in bl/bl
31 diac hypertrophy which suggests that raising growth/differentiation factor 11 levels may be useful to
33 epidermal growth factor receptor], GDF-11/8 [growth differentiation factor-11/8], and RGMC [hemojuvel
34 sought to determine the usefulness of plasma growth differentiation factor 15 (GDF-15) for risk strat
45 and additional potential biomarkers, such as growth differentiation factor 15 (GDF15) and cell free m
47 f 15 proteins strongly associated with POHP, growth differentiation factor 15 (GDF15) and WAP four-di
48 and subsequent targeted validation revealed growth differentiation factor 15 (GDF15) as a central co
50 found that MEG3 stimulates expression of the growth differentiation factor 15 (GDF15) by enhancing p5
52 We have previously found up-regulation of growth differentiation factor 15 (GDF15) in glioblastoma
58 fusion increases kidney, hepatic, and plasma growth differentiation factor 15 (GDF15) levels in chow
59 ases fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) levels via acti
61 supports that pharmacological application of growth differentiation factor 15 (GDF15) suppresses appe
66 nted increases in ISR gene targets including growth differentiation factor 15 (GDF15), a negative reg
67 analysis, which revealed increased levels of growth differentiation factor 15 (GDF15), along with inc
68 F21), bone morphogenetic protein 8b (BMP8b), growth differentiation factor 15 (GDF15), angiopoietin-l
69 predictors across multiple diseases, such as growth differentiation factor 15 (GDF15), as well as uni
70 ermore, CXCL12 induces downregulation of the growth differentiation factor 15 (GDF15), insulin-like g
76 ctor, IL-1, IL-6, and CXCR1/2 chemokines and growth differentiation factor 15 also seems to be very c
77 l included 8 items: age (A), biomarkers (B) (growth differentiation factor 15 and N-terminal pro-B-ty
81 2 large studies, high plasma levels of MIC1 (growth differentiation factor 15) before diagnosis of CR
83 Smad7 upregulation via Smad3, whereas GDF15 (growth differentiation factor 15) induced Smad7 through
86 of macrophage inhibitory cytokine-1 (MIC1 or growth differentiation factor 15), a marker of inflammat
87 oponin I), CRP (C-reactive protein), GDF-15 (growth differentiation factor 15), GAL-3 (galectin-3), a
89 retic peptide, 0.77 [95% CI, 0.68-0.87]; and growth differentiation factor 15, 0.68 [95% CI, 0.58-0.7
90 [207-491] pmol/L vs 152 [90-247] pmol/L; and growth differentiation factor 15, 2.26 [1.44-4.35] vs 1.
91 edictors of CV death/MI were the biomarkers, growth differentiation factor 15, and N-terminal pro-B-t
92 ical and genetic predictors, with plexin B2, growth differentiation factor 15, and renin emerging as
93 yocardial inflammation and fibrosis, such as growth differentiation factor 15, are also powerful pred
95 proteins revealed differential expression of growth differentiation factor 15, dickkopf-related prote
97 the antifibrotic and antiinflammatory factor growth differentiation factor 15, which protects the hea
100 tumor necrosis factor a receptor II], GDF15 [growth differentiation factor 15], cystatin-C, HGBA1C [H
101 -alpha], jun-D [JunD proto-oncogene], GDF15 [growth differentiation factor 15], FGL1 [fibrinogen like
102 ensitive troponin-T (>14 ng/L), and elevated growth-differentiation factor 15 (>1109 ng/L) identified
105 rming growth factor beta superfamily member, growth-differentiation factor 15 (Gdf15), that is expres
106 of NT-proBNP, high-sensitive troponin-T, and growth-differentiation factor 15 identify patients at hi
107 (NT-proBNP), high-sensitive troponin-T, and growth-differentiation factor 15 with cardiovascular eve
108 t (NT-proBNP, high-sensitive troponin-T, and growth-differentiation factor 15) at the time of study i
109 natriuretic peptide, cardiac troponin-T, and growth-differentiation factor 15) to apply the previousl
112 clin-dependent kinase inhibitor 1a (CDKN1A), Growth/differentiation factor 15 (GDF15), and Prostaglan
113 be differentiated by their ability to induce growth/differentiation factor 15 (GDF15), independent of
114 ith aging markers in human plasma, including Growth/differentiation factor 15 (GDF15), stanniocalcin
115 es circulating levels of the peptide hormone growth/differentiation factor 15 (GDF15), which has been
117 ns in hepatokine expression (e.g., increased growth/differentiation factor 15 [GDF15] and fibroblast
118 culation, including placental growth factor, growth/differentiation factor 15, and matrix metalloprot
119 e], BCAN [brevican core protein], and GDF15 [growth/differentiation factor 15]), retained favorable d
120 din and its putative pathological suppressor growth differentiation factor-15 (GDF-15) in patients wi
121 o-brain natriuretic peptide (NT-proBNP), and growth differentiation factor-15 (GDF-15) in relation to
124 B-type natriuretic peptide (NT-proBNP), and growth differentiation factor-15 (GDF-15) over 12 months
126 (N-terminal B-type natriuretic peptide), and growth differentiation factor-15 (GDF-15), as well as in
127 ng were the concentrations of the biomarkers growth differentiation factor-15 (GDF-15), high-sensitiv
128 IMD4), fibroblast growth factor 23 (FGF-23), growth differentiation factor-15 (GDF-15), pulmonary sur
131 tio [HR], 2.13; 95% CI, 1.52-2.99; P<0.001), growth differentiation factor-15 (HR, 1.67; 95% CI, 1.32
132 = 0.01), macrophage accumulation (P < 0.01), growth differentiation factor-15 (P = 0.0001), and calci
133 tween pretransplant inflammatory biomarkers (growth differentiation factor-15 [GDF-15], interleukin-6
134 siRNA significantly decreased expression of growth differentiation factor-15 and monocyte chemotacti
135 y with total hemoglobin, yet negatively with growth differentiation factor-15 and non-transferrin-bou
139 tein, D-dimer, fibrinogen, homocysteine, and growth differentiation factor-15 levels (P<0.001 for all
140 enuated the stress responsive factor GDF-15 (growth differentiation factor-15) and increased the inte
141 rowth factor binding protein 7), and GDF-15 (growth differentiation factor-15) were the top individua
142 te biology (fatty acid binding protein-4 and growth differentiation factor-15), angiopoietin-2 (relat
143 associated with both HF subtypes (NT-proBNP, growth differentiation factor-15, and C-reactive protein
144 diovascular stress, we measured soluble ST2, growth differentiation factor-15, and high-sensitivity t
146 oADM (pro-adrenomedullin; HR, 1.60), GDF-15 (growth differentiation factor-15; HR, 1.47), WFDC2 (WAP
149 , N-terminal pro-B-type natriuretic peptide, growth-differentiation factor-15, and high-sensitivity C
150 ed the increased expression of TGF-beta1 and growth/differentiation factor-15 (GDF-15) in RGDSP cultu
152 orming growth factor)/activin pathway (GDF2 [growth differentiation factor 2]/BMP9 [bone morphogenic
154 tion but the role of the zebrafish ortholog, Growth differentiation factor 3 (Gdf3), has not been ful
156 th factor beta (Tgfbeta) family member Gdf3 (growth-differentiation factor 3), a close relative of Xe
157 holamine-induced lipolysis by downregulating growth differentiation factor-3 (GDF3) and monoamine oxi
158 integrin alpha-4 (Itga4) and to up-modulate growth differentiation factor-3 (Gdf3), oncostatin-M (On
161 proteins 70 and 90, chemokine receptor 4 and growth differentiation factor 5 as the main mediators of
167 a fraction of a precursor cells that express growth/differentiation factor 5 (Gdf5), the transcriptio
170 little skate embryos shows the expression of growth differentiation factor-5 (Gdf5) and beta-catenin
172 achypodism (bp) which is due to mutations in growth/differentiation factor-5 (Gdf-5) (6), the mouse h
175 dying glaucoma patients, we identified GDF7 (growth differentiation factor 7) hypomethylation as a cr
180 g GDF11 or its closely related family member growth differentiation factor 8 actually impairs skeleta
181 phenotype suggests that the ablated product, growth differentiation factor 8 or 'myostatin', may be o
182 of canonical wnt signaling, as well as GDF8 (growth differentiation factor 8), PDGF-D, and neuregulin
185 ntified a new murine TGF-beta family member, growth/differentiation factor-8 (GDF-8), which is expres
186 , bone morphogenetic protein 15 (BMP-15) and growth differentiation factor 9 (GDF-9), were up-regulat
187 we investigated the therapeutic potential of growth differentiation factor 9 (GDF-9)-overexpressing E
190 ed bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9) are key regulator
191 Bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9) are oocyte-specif
193 ction of Dhh/Ihh in granulosa cells requires growth differentiation factor 9 (GDF9) from the oocyte.
196 o had an increase in the expression ratio of growth differentiation factor 9 (GDF9):bone morphogeneti
198 Although signaling of activins, TGF-betas, growth differentiation factor 9, and nodal converge pref
199 -derived paracrine factors, particularly the growth differentiation factor 9-bone morphogenetic prote
200 e null for the oocyte-specific gene product, growth differentiation factor-9 (GDF-9), a member of the
203 ment, we have uncovered a new family member, growth differentiation factor-9 (GDF-9), which is requir
205 criptional activation of pro-growth ligands (growth differentiation factor/bone morphogenetic protein
207 (PTN) is an 18-kDa heparin-binding secretory growth/differentiation factor for different cell types.
209 ensitivity cardiac troponin T (hs-cTnT), and growth differentiation factor (GDF)-15 for HF risk strat
210 pro-B-type natriuretic peptide (NT-proBNP), growth differentiation factor (GDF)-15, myeloperoxidase
211 CTD-negative" families, both of which harbor growth differentiation factors (GDF6, GDF3) implicated i
212 tor-beta superfamily, including activins and growth differentiation factors (GDFs), is aberrantly exp
213 ably alter NOG's ability to bind to BMPs and growth-differentiation factors (GDFs) in a subtle way, t
214 gene, human epoxide hydrolase (EPHX), human growth/differentiation factor (GOF-1), human myocyte-spe
215 , a novel fusion protein, binds activins and growth differentiation factors in the attempt to restore
216 is a fusion protein that traps activins and growth differentiation factors involved in pulmonary art
218 rowth factor beta/bone morphogenetic protein/growth differentiation factor (TGFbeta/BMP/GDF)-related
219 lexes of transforming growth factor-B family growth/differentiation factors with their prodomains are
220 es of transforming growth factor-beta family growth/differentiation factors with their prodomains are